An additional benefit of AF formation was seen in multidrug resistant transporter studies which demonstrate that AF, in contrast to AF-HPA, is not a P-glycoprotein 1 (Pgp) substrate. This evidence concerns the gene ABCB1 and atrial fibrillation.